下一代益生菌的研究趋势
Muhammad Adeel Hasnain1, Dae-Kyung Kang2, Gi-Seong Moon1,3,4
1Major in IT·Biohealth Convergence, Department of IT·Energy Convergence, Graduate School, Korea National University of Transportation, Chungju, 27469 Republic of Korea.
Food science and biotechnology
|August 12, 2024
概括
下一代益生菌采用先进的OMIC技术开发,为肠道失生症和相关健康状况提供有针对性的解决方案. 这些量身定制的益生菌在特定疾病和消费者需求方面表现有前途.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 肠道微生物群在宿主健康中起着至关重要的作用,影响新陈代谢,免疫力和疾病保护.
- 微生物失衡 (失生症) 与各种肠道,全身,代谢和神经退行性疾病有关.
- 传统的益生菌旨在恢复肠道平衡,但下一代益生菌提供了更有针对性的治疗潜力.
研究的目的:
- 审查下一代益生菌的最新进展.
- 讨论量身定制的益生菌在解决特定健康状况方面的潜力.
- 确定将下一代益生菌概念转化为临床现实的挑战.
主要方法:
- 审查关于下一代益生菌的当前科学文献.
- 对使益生菌发展成为可能的OMIC技术 (高通量测序,生物信息学) 的分析.
- 讨论机理学研究和临床应用.
主要成果:
- 下一代益生菌正在使用先进技术开发,以获得特定的健康益处.
- 这些定制的益生菌显示出改善向疾病状况的潜力.
- 在了解下一代益生菌的机制方面取得了重大进展.
结论:
- 下一代益生菌代表了微生物组治疗的前沿.
- 量身定制的益生菌有可能满足消费者特定的健康需求.
- 克服当前的挑战对于下一代益生菌的成功临床转化至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Microbes in the Production of Fermented Foods
Lactic acid bacteria (LAB) and molds are instrumental in fermenting plant-based foods to enhance preservation and ensure year-round availability. These microbial processes convert plant carbohydrates into organic acids and other metabolites that inhibit spoilage organisms and contribute to the sensory qualities of the final product.In sauerkraut production, cabbage goes through a microbial succession that starts with cocci such as Leuconostoc mesenteroides. These microbes begin fermentation by...
Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


